"US Announces Initial Drugs for Medicare Price Negotiation, Including Eliquis and Jardiance"

The Biden administration has released a list of 10 prescription drugs that will be subject to price negotiations by the U.S. Medicare health program, including popular medications such as Eliquis, Xarelto, and Januvia. The program aims to decrease prices for up to 9 million seniors and save $25 billion per year on drug prices by 2031. Drugmakers targeted on the list have expressed concerns about stifling innovation and impacting the quality of care. The negotiated prices will go into effect in 2026, and the program is expected to free up Medicare's budget to cover other drugs.